Section Arrow
VIVS.NASDAQ
- VivoSim Lab Inc
(Financial Status)
Quotes are at least 15-min delayed:2026/08/02 01:45 EDT
Regular Hours
Last
 0.3446
-0.0414 (-10.73%)
Day High 
0.419 
Prev. Close
0.386 
1-M High
1.57 
Volume 
5.88M 
Bid
0.32
Ask
0.326
Day Low
0.3231 
Open
0.415 
1-M Low
0.314 
Market Cap 
1.35M 
Currency 美元 
P/E 0.47 
%Yield -- 
10-SMA 0.44 
20-SMA 0.64 
50-SMA 0.98 
52-W High 5.3 
52-W Low 0.314 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-5.35/-0.75
Enterprise Value
1.35M
Balance Sheet
Book Value Per Share
-0.31
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
131.00K
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
REPLReplimune Group11.2+5.79+107.02%-- 
GOSSGossamer Bio0.1695-0.0088-4.94%-- 
JUNSJupiter Neurosciences Inc0.09-0.0075-7.69%-- 
KPTIKaryopharm Therapeutics Inc.1.92-5.09-72.61%-- 
IOVAIovance Biotherapeutics4.07-0.62-13.22%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
VivoSim Labs Inc is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The Company provides liver and intestinal toxicology insights using its new approach methodologies and models and offers liver toxicology predictive screening and research services, as well as services to predict and study the intestinal side effect profiles of therapeutic candidates at all stages of drug development. Its 3D human tissue platform includes expertise in 3D organoids, such as spheroids, and proprietary cell culture techniques.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.